Exploratory Study of Some Synovial Fluid Inflammation Mediatorsunder Diacerhein in Knee Osteoarthritis Patients. Phase IV Study.
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2010
At a glance
- Drugs Diacerein (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Laboratoires Negma; Wockhardt
- 31 Aug 2018 Biomarkers information updated
- 09 Mar 2010 Actual end date (October 2008) added as reported by ClinicalTrials.gov.
- 09 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.